IPN Weekly

IPN Weekly

Your Weekly Interventional Psychiatry News Brief
• TMS
• Ketamine/Spravato
• Neurofeedback
From InterventionalPsychiatry.org (IPN)


TMS

Stay up to date with the latest in Transcranial Magnetic Stimulation (TMS)—an FDA-approved, noninvasive treatment for depression that continues to expand in reach and impact. Each week we cover reimbursement updates and insurance coverage changes, new clinical protocols and accelerated treatment models, breakthrough research on efficacy, and stories from providers at the forefront of neuromodulation. From practical insights for clinics to emerging trends in patient care, we keep you informed on how TMS is paving new paths in mental health care.



Ketamine Therapy

Explore the evolving landscape of ketamine therapy, from FDA-approved esketamine (Spravato) to off-label infusion protocols used worldwide. Our coverage highlights the latest clinical trials, payer updates on insurance coverage, safety considerations, and integration with psychotherapy. We break down emerging best practices, regulatory developments, and patient outcomes so you can stay ahead in this rapidly growing treatment space.



Psychedelic-Assisted Therapy

Get the latest on psychedelic-assisted treatments, including psilocybin, MDMA, and other compounds making headlines in research and regulation. We track clinical trial results, FDA breakthrough therapy designations, and cultural conversations shaping public perception. Each week, we provide context on how psychedelic science intersects with mental health practice, what providers need to know, and what patients should understand about risks, access, and future availability.


Stay Ahead in Mental Health Innovation

Get the latest in interventional psychiatry delivered straight to your inbox.
✔ New treatment breakthroughs & protocols
✔ Insurance & reimbursement updates
✔ Research on TMS, ketamine, psychedelics & more
✔ Insights for providers, patients, and innovators
Never miss an update — join the IPN Weekly community today.


© www.interventionalpsychiatry.org

Thank you

Thank you for joining IPN Weekly!You’re now subscribed to receive the latest updates in Interventional Psychiatry.👉 Check your inbox (and spam/junk folder) for a confirmation email.
👉 To make sure you never miss an issue, please add [email protected]
to your contacts.
We’re excited to keep you informed with news, research, and insights that matter.